TEL

AU10TIX Boosts FXCM ID Document Approval Rates by 29%, Enabling Revenue Growth

Retrieved on: 
Wednesday, April 3, 2024

TEL AVIV, Israel and LONDON, April 3, 2024 /PRNewswire/ -- AU10TIX, a global technology leader in identity verification and management, and Stratos Group of companies (collectively, the 'Stratos Group' or 'FXCM'), a leading provider of online foreign exchange (FX) trading, stocks and other CFD trading and related services, today announced a successful partnership that has bolstered user security and optimized the onboarding process on the FXCM platform, increasing ID document approval rates by 29% and impacting revenue growth.

Key Points: 
  • FXCM solved this business challenge by integrating AU10TIX's Identity Verification (IDV) Suite , Web SDK and biometric solutions into the FXCM platform.
  • AU10TIX's advanced algorithms and extensive security databases streamlined FXCM's validation processes, resulting in a significant improvement in document approval rates from 62% to 80%.
  • The swifter onboarding resulted in lower abandonment rates and thus expanded the opportunity for revenue growth.
  • "At FXCM, ensuring a seamless and secure onboarding experience for our customers is a top priority," said Teodora Mladenova, eKYC Product manager at FXCM.

GK8 Launches Tokenization Wizard, Enabling Institutional-Grade Tokenization of Any Asset

Retrieved on: 
Wednesday, April 3, 2024

Tokenization presents vast opportunities for businesses and investors, with some analysts predicting tokenized assets will reach $4 trillion in market value by 2030.

Key Points: 
  • Tokenization presents vast opportunities for businesses and investors, with some analysts predicting tokenized assets will reach $4 trillion in market value by 2030.
  • "Our Tokenization Wizard, with its user-friendly interface and customizable options, revolutionizes the tokenization process, enabling users to tokenize assets with just a few clicks.
  • Institutions can now leverage this innovative technology to facilitate new revenue streams, enabling them to adopt these new capabilities securely."
  • Tokenization of any asset - The Tokenization Wizard can create any kind of token, ranging from NFTs and utility tokens to security tokens and real-world assets.

DESPITE IMMEDIATE CHALLENGES TO ISRAEL'S TECH SECTOR AFTER OCTOBER 7TH, NEW REPORT SHOWS RESILIENCE IN PRIVATE INVESTMENT ROUNDS, M&A DEALS & NEW FUNDS

Retrieved on: 
Tuesday, April 2, 2024

Private investment rounds: There were 220 private investment rounds announced since October 7th with an estimated $3.1 billion raised.

Key Points: 
  • Private investment rounds: There were 220 private investment rounds announced since October 7th with an estimated $3.1 billion raised.
  • The most notable investment was in Next Insurance which saw two foreign VCs invest $265 million.
  • The leading sectors in the number of rounds were health tech (47), enterprise software solutions (42) and security technologies (39).
  • New Funds: Since October 7th, over 20 new funds were established raising a total of $1.7 billion.

Marketeam.ai Lunches Ella, the Autonomous AI Social Media Marketing Agent for SMBs, Marking the First Step in Marketeam.ai's Ambitious Rollout of Specialized AI Marketing Agents

Retrieved on: 
Tuesday, April 2, 2024

TEL AVIV, Israel, April 2, 2024 /PRNewswire/ --  Marketeam announces the launch of myella.ai, the first in a series of cutting-edge AI agents specially trained in distinct marketing domains. Ella is designed to autonomously manage organic social media marketing, setting a new standard for digital marketing efficiency and innovation for small and medium-sized businesses (SMBs).

Key Points: 
  • Ella is designed to autonomously manage organic social media marketing, setting a new standard for digital marketing efficiency and innovation for small and medium-sized businesses (SMBs).
  • Ella represents the spearhead of Marketeam.ai's ambitious vision to provide SMBs with an entire team of autonomous AI experts, each focused on a key area of marketing.
  • Ella's expertise in social media is just the beginning, as Marketeam.ai plans to introduce a full lineup of specialized AI agents to comprehensively address the varied aspects of business marketing & growth.
  • Members on this list will gain early access to the company's suite of AI marketing agents, each a specialist in their domain, poised to deliver a comprehensive, AI-powered marketing revolution.

ADAMA Launches New Cereal Fungicide Forapro® for Supercharged Disease Control and Higher Yields

Retrieved on: 
Tuesday, April 2, 2024

Forapro® offers the double boosting effect of two Active Ingredients together with ADAMA's unique Asorbital® Formulation Technology.

Key Points: 
  • Forapro® offers the double boosting effect of two Active Ingredients together with ADAMA's unique Asorbital® Formulation Technology.
  • It delivers powerful results for both wheat and barley and is effective against early season diseases such as Powdery Mildew, Septoria and Rust.
  • Due to its unique formulation and dual active ingredients, Forapro® provides excellent control in T1 that keeps disease infestation levels in check until T2 spraying.
  • "Forapro® delivers superior T1 control of Septoria, Yellow Rust, and Powdery Mildew, improving crop yields.

IBI Investment House Selects ViewTrade's NextGen Platform to Fuel New Retail Trading Capabilities

Retrieved on: 
Tuesday, April 2, 2024

JERSEY CITY, N.J. and TEL AVIV, Israel, April 2, 2024 /PRNewswire/ -- ViewTrade Holding Corporation ("ViewTrade") and IBI Investment House ("IBI") today announced a strategic partnership to provide IBI clients with unprecedented access to international trading markets through a new retail trading experience powered by ViewTrade's NextGen platform. By tapping into NextGen's suite of front- and back-end capabilities, IBI's trading and wealth management customers will benefit from a refreshed, modern user experience providing seamless functionality for trade execution.

Key Points: 
  • Partnership provides IBI clients with plug-and-play technology, including access to international trading markets
    JERSEY CITY, N.J. and TEL AVIV, Israel, April 2, 2024 /PRNewswire/ -- ViewTrade Holding Corporation ("ViewTrade") and IBI Investment House ("IBI") today announced a strategic partnership to provide IBI clients with unprecedented access to international trading markets through a new retail trading experience powered by ViewTrade's NextGen platform.
  • By tapping into NextGen's suite of front- and back-end capabilities, IBI's trading and wealth management customers will benefit from a refreshed, modern user experience providing seamless functionality for trade execution.
  • In addition to international market access, IBI clients will benefit from ViewTrade's support for fractional share trading, equity options trading and other in-demand products, and can seamlessly add other products via ViewTrade over time.
  • Livnat Mizrahi Rinsky, CEO of Israel Brokerage and Investments at IBI Investment House echoed this sentiment saying, "We are excited to be partnering with ViewTrade to utilize their NextGen solutions.

IBI Investment House Selects ViewTrade's NextGen Platform to Fuel New Retail Trading Capabilities

Retrieved on: 
Tuesday, April 2, 2024

JERSEY CITY, N.J. and TEL AVIV, Israel, April 2, 2024 /PRNewswire/ -- ViewTrade Holding Corporation ("ViewTrade") and IBI Investment House ("IBI") today announced a strategic partnership to provide IBI clients with unprecedented access to international trading markets through a new retail trading experience powered by ViewTrade's NextGen platform. By tapping into NextGen's suite of front- and back-end capabilities, IBI's trading and wealth management customers will benefit from a refreshed, modern user experience providing seamless functionality for trade execution.

Key Points: 
  • Partnership provides IBI clients with plug-and-play technology, including access to international trading markets
    JERSEY CITY, N.J. and TEL AVIV, Israel, April 2, 2024 /PRNewswire/ -- ViewTrade Holding Corporation ("ViewTrade") and IBI Investment House ("IBI") today announced a strategic partnership to provide IBI clients with unprecedented access to international trading markets through a new retail trading experience powered by ViewTrade's NextGen platform.
  • By tapping into NextGen's suite of front- and back-end capabilities, IBI's trading and wealth management customers will benefit from a refreshed, modern user experience providing seamless functionality for trade execution.
  • In addition to international market access, IBI clients will benefit from ViewTrade's support for fractional share trading, equity options trading and other in-demand products, and can seamlessly add other products via ViewTrade over time.
  • Livnat Mizrahi Rinsky, CEO of Israel Brokerage and Investments at IBI Investment House echoed this sentiment saying, "We are excited to be partnering with ViewTrade to utilize their NextGen solutions.

Voiceitt puts its AI to work, making the remote workplace inclusive

Retrieved on: 
Monday, April 1, 2024

TEL AVIV, Israel and STAMFORD, Conn. , April 1, 2024 /PRNewswire/ -- Voiceitt, the Israel-based leader in speech recognition technology for non-standard speech, announces its collaboration with Virtualahan, a leading organization in the Philippines that recruits and trains individuals with disabilities for meaningful employment opportunities. Together, the two organizations leverage cutting-edge AI-driven technologies to give people with disabilities a voice and facilitate opportunities for employment.

Key Points: 
  • With Voiceitt, people with disabilities can get a job, keep a job, and enjoy greater productivity and satisfaction on the job.
  • Voiceitt and Virtualahan are committed to changing these statistics by creating inclusive workplaces where individuals with disabilities can contribute their unique talents and skills.
  • "Our tech expands employment opportunities and can improve workplace productivity," said Alyson Pace, CEO of Voiceitt.
  • Voiceitt partners with organizations such as the Department of Intellectual and Developmental Disabilities in Tennessee to evaluate how technologies like Voiceitt can advance critical employment opportunities.

BioLineRx Announces $6 Million Registered Direct Offering

Retrieved on: 
Monday, April 1, 2024

Each ADS represents fifteen (15) ordinary shares, par value NIS 0.10 per share, of BioLineRx.

Key Points: 
  • Each ADS represents fifteen (15) ordinary shares, par value NIS 0.10 per share, of BioLineRx.
  • The offering is expected to close on or about April 1, 2024, subject to the satisfaction of customary closing conditions.
  • The gross proceeds from the offering (without taking into account any proceeds from any future exercises of warrants), before deducting the placement agent's fees and other offering expenses payable by the Company, are expected to be $6.0 million.
  • The offering is being made by the Company pursuant to its shelf registration statement on Form F-3 (File No.

Lutris Pharma Appoints Life Sciences and Pharmaceutical Entrepreneur Moshe "Mori" Arkin to Its Board of Directors

Retrieved on: 
Monday, April 1, 2024

TEL AVIV, Israel, April 1, 2024 /PRNewswire/ -- Lutris Pharma , a clinical stage biopharmaceutical company focused on improving anti-cancer therapies by reducing dose limiting side effects, today announced the appointment Moshe "Mori" Arkin, a life sciences and pharmaceutical entrepreneur, and Founder and Chairman of Arkin Holdings, to its Board of Directors.

Key Points: 
  • TEL AVIV, Israel, April 1, 2024 /PRNewswire/ -- Lutris Pharma , a clinical stage biopharmaceutical company focused on improving anti-cancer therapies by reducing dose limiting side effects, today announced the appointment Moshe "Mori" Arkin, a life sciences and pharmaceutical entrepreneur, and Founder and Chairman of Arkin Holdings, to its Board of Directors.
  • "Mori is one of Israel's most successful life sciences and pharmaceutical entrepreneurs with an extraordinary background spanning decades in the industry," stated Antoni Ribas, M.D., Ph.D., Chairman and Founder of Lutris Pharma.
  • "Arkin Bio Ventures has been an investor in Lutris Pharma since its inception and has been a steadfast supporter of the Company, ever since.
  • In 2011, they formed the Arkin Family Foundation, which supports organizations and projects in education, arts and culture, welfare, healthcare, civil rights, and Jewish-Arab coexistence.